http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101679390-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e13cf25eb1bef6199475314477618b46
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T428-2982
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4178
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178
filingDate 2008-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f9b3ac8b441d69ff24b998bfb0024cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d3599f9c07e1925a14a8412eb4d65f5
publicationDate 2010-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-101679390-A
titleOfInvention Ground crystal of olmesartan medoxomil
abstract The present invention provides a medicament containing olmesartan medoxomil wherein the dissolution property from the medicament is controlled. An olmesartan medoxomil having a particle diameter at 90% cumulative volume of 75 [mu]m or less, a process for the production of a medicament containing olmesartan medoxomil which uses the olmesartan medoxomil having such particle diameter, and the like are also provided.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104398483-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104398483-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105663070-A
priorityDate 2007-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87060060
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452816548
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449846142
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID41568
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415828206
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419571304
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448897384
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID517273
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449000177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107665
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424552091
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4329331
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID130881
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411174055
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID330167
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID122903
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415822791
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID237575
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14080
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID158781
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID237575
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24441
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID41568
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID330167

Total number of triples: 55.